This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| A. | Classification codes | ICD-10 M93.1 | Special Copayment Reduction V299 |
| B. | Synonyms | Kienböck disease of adults |
| C. | Adult onset | High — this disease itself refers to the form that manifests in adults, and it is mainly diagnosed in adults in their 20s~40s. |
| 1. | History | First described by Kienböck (1910); the adult form is classified as M93.1, separate from the juvenile form (M92.2). |
| 2. | Causes | Vascular vulnerability of the lunate + negative ulnar variance + repetitive trauma and overload. |
| 3. | Genetics | No single-gene cause; genetic predisposition in anatomical variation and vascular structure. |
| 4. | General epidemiology | Adult male predominance in the 20s~40s; dominant hand involvement; an uncommon rare disease. |
| 5. | Pathophysiology | Lunate ischemia → necrosis → collapse → degenerative carpal arthritis. |
| 6. | Symptoms | Dorsal wrist pain, swelling, decreased grip strength, restricted motion. |
| 7. | Signs | Lunate tenderness; X-ray and MRI findings of necrosis and collapse. |
| 8. | Screening | X-ray + MRI in adults with wrist pain; measurement of ulnar variance. |
| 9. | Diagnosis | Lichtman stages (I~IV); integrated MRI, CT and X-ray assessment. |
| 10. | Treatment | By stage: immobilization → decompression osteotomy → vascularized bone graft → salvage procedures. |
| 11. | Prognosis | Good with early treatment; limited functional recovery in advanced stages. |
| 12. | Prevention | Avoid wrist overload; early diagnosis and treatment. |
| 13. | References | List of key references and guidelines |
Kienböck disease of adults is a disease first described in 1910 by the Austrian radiologist Robert Kienböck, who identified on X-ray avascular necrosis of the lunate in adult patients with wrist pain. Kienböck described this finding as 'malacia of the lunate' and suggested that repetitive trauma or occupational overload might be the cause. For decades thereafter, debate continued over the cause, pathophysiology and optimal treatment of this disease.
In 1977, Lichtman proposed a clinical and radiological staging classification (Stage I~IV), providing a common language for treatment decision-making. ICD-10 distinguishes the adult form as M93.1 and the juvenile form (childhood and adolescence) as M92.2, and this code classification reflects differences in clinical course and treatment strategy. With the introduction of MRI in the late 20th century, early diagnosis became possible, and advances in surgical techniques, including vascularized bone grafts, greatly widened the range of treatment options. Even now, randomized controlled studies on the optimal treatment strategy are lacking, so treatment guidelines rely heavily on expert consensus and case studies.
The cause of Kienböck disease in adults is complex and is understood to arise from the interaction of anatomical vulnerability of the blood supply, mechanical load and trauma. The lunate is one of the bones with the most vulnerable blood supply among the 8 carpal bones, and about 7~26% of all lunates show a single-vessel supply pattern, making them particularly vulnerable to ischemia. Negative ulnar variance is known to be a major risk factor that increases the load concentrated on the lunate, promoting microfractures and vascular damage.
As occupational causes, there is epidemiological evidence that work involving repetitive, excessive use of the wrist (carpentry, drilling, typing, etc.) is associated with the development of Kienböck disease. In some cases it arises when the lunate blood supply is cut off after acute trauma, which can be regarded as post-traumatic avascular necrosis. In addition, coagulation disorders (antiphospholipid antibody syndrome, protein C and S deficiency, etc.) have rarely been reported to cause lunate necrosis through thrombotic vascular occlusion. Secondary causes such as long-term steroid use, sickle cell disease and post-irradiation are also known.
No single-gene cause has been identified for Kienböck disease in adults. Familial clustering has rarely been reported, but this is presumed to be due to genetic sharing of anatomical variations (ulnar length ratio, lunate vascular structure), and it is not classified as a single-gene disorder. Negative ulnar variance (ulnar minus variance) is a partly heritable trait, and the resulting increase in disease risk may be the cause of familial clustering.
Studies have examined whether coagulation-related gene variants (Factor V Leiden, MTHFR, prothrombin 20210A, etc.) increase the risk of avascular necrosis of the lunate, but there are no definitive results. At present it is not classified as a single-gene disorder indicated for genetic counseling, and genetic testing is not included in the standard diagnostic process.
Kienböck disease in adults is a rare disease, and accurate incidence or prevalence statistics are limited. According to clinical studies, it occurs most often in adults in their 20s~40s, particularly young adults in their 20s~30s, and men are affected about 2~3 times more often than women. Involvement of the dominant hand is more common at about 60~70%, but the nondominant hand can also be involved. Bilateral occurrence is rare, reported in less than 5~10% of all cases.
When occupational overload is involved, cases may be concentrated in certain occupational groups (manual laborers, farmers, athletes). In Korea it is registered and managed under the Special Copayment Reduction program (V299), and nationwide incidence statistics can be estimated from health insurance claims data, but the actual diagnosis rate may be low due to low awareness. The association with negative ulnar variance in Western literature is presumed to apply similarly to East Asian populations.
The pathogenesis of Kienböck disease proceeds as a multistep process. First, the lunate blood supply is damaged by a combination of vascular vulnerability (single-vessel supply) and mechanical overload. Second, marrow ischemia due to vascular damage occurs, which appears on MRI as marrow edema with low T1 and high T2 signal. Third, if the ischemia does not resolve, marrow cells become necrotic, and subsequently the bone structure itself enters a state of avascular necrosis.
Fourth, revascularization is attempted, but in adults it is less likely to succeed than in the juvenile form. If revascularization fails, the lunate gradually loses mechanical strength, and compression, fragmentation and collapse progress. Fifth, collapse of the lunate leads to abnormal carpal alignment (DISI deformity, etc.), and secondarily the cartilage of surrounding carpal joints is damaged, leading to pancarpal degenerative arthritis. This last stage corresponds to Lichtman Stage IV, at which point the treatment goal becomes preservation of function of the whole joint rather than treatment of the lunate itself.
The most common early symptom of Kienböck disease in adults is chronic pain in the central dorsal side of the wrist. The pain tends to worsen with activity and be partially relieved by rest, but in advanced cases it persists even at rest. Wrist swelling, especially diffuse dorsal swelling, may accompany it, and grip strength is markedly reduced. Pain intensifies with making a fist or with wrist flexion and extension, and the range of motion becomes progressively limited.
Symptoms usually progress slowly over months to years, and in some cases the delay to diagnosis averages 1~2 years. Early on, it is often misdiagnosed as a simple wrist sprain or a triangular fibrocartilage complex (TFCC) injury. In advanced disease, wrist range of motion decreases to 30~50% of normal, and fine hand movements (writing, keyboard typing, etc.) may also become difficult.
On physical examination, direct pressure over the lunate (center of the dorsal wrist, between the base of the third metacarpal and the radius) elicits deep tenderness. Diffuse swelling is observed on the dorsal wrist joint, and dynamometer measurement can confirm a marked decrease in grip strength compared with the unaffected side (often to 30~50%). The range of wrist flexion and extension is limited, and pain at the lunate may also be reproduced with resisted thumb extension.
On plain X-ray, increased density or mild flattening of the lunate is observed early, and with progression, collapse, fragmentation and loss of height of the lunate, and further collapse of the entire carpus (carpal collapse), appear. MRI is the most sensitive tool and can detect vascular abnormalities early, even in Stage I, as low T1 signal and reduced contrast enhancement. CT is useful for assessing detailed fragmentation of bone structure and microfractures.
When adults have chronic wrist pain of unknown cause, especially dorsal pain, including Kienböck disease in the differential diagnosis is the key to early detection. At the initial visit, plain X-rays (AP and lateral) are taken to assess abnormal lunate density and ulnar variance. Even if X-rays are normal, MRI is performed immediately if clinical suspicion is high. MRI is the only test that can detect the marrow edema of Stage I and is the decisive tool for early diagnosis.
Bone scintigraphy can show increased or decreased uptake in the lunate (cold spot), but its specificity is low, so it is used only as an adjunct when MRI is not possible. Because measurement of negative ulnar variance is also needed for surgical planning, it is recommended that it be measured by a standardized method during diagnostic X-ray imaging. When a coagulation disorder is suspected, related tests (APLA, protein C and S, Factor V Leiden, etc.) may also be considered.
The diagnosis of Kienböck disease in adults is made by integrating characteristic clinical findings (dorsal wrist tenderness, decreased grip strength) with imaging findings. The Lichtman staging classification is used as standard: Stage I (normal X-ray, low T1 signal on MRI); Stage II (abnormal density on X-ray, shape preserved); Stage IIIa (lunate collapse, normal scaphoid alignment); Stage IIIb (lunate collapse + fixed scaphoid flexion); Stage IV (pancarpal degenerative arthritis). MRI, CT and X-ray findings contribute complementarily to diagnosis at each stage.
The differential diagnosis includes triangular fibrocartilage complex (TFCC) injury, scaphoid fracture and nonunion, carpal instability, radiocarpal arthritis and lunate fracture. Taking a history of systemic disease is important to exclude secondary causes (steroid-induced, sickle cell disease, lupus vasculitis, etc.). Tissue biopsy is generally not needed but may be performed when differentiation from a tumor is required.
Treatment of Kienböck disease in adults is individualized according to stage, ulnar variance, and the patient's age, occupation and functional demands. In Stage I~II, conservative treatment reducing load on the lunate with splinting or cast immobilization may be tried for 3~6 months. However, in adults the likelihood of spontaneous healing is lower than in the juvenile form, so surgical intervention is considered sooner. When negative ulnar variance is present, radial shortening osteotomy or ulnar lengthening has proven effective as the first surgical option.
Vascularized bone grafts (e.g., 4th and 5th volar interosseous artery flap grafts) promote revascularization of the lunate and can be performed up to Stage IIIa. Intercarpal arthrodesis and silicone implant insertion after lunate excision (now rarely performed) were also used in the past. In Stage IIIb~IV, proximal row carpectomy or total wrist arthrodesis is performed as a salvage procedure. Total wrist arthroplasty may be considered in certain patient groups, but long-term outcome data are limited.
The prognosis of Kienböck disease in adults varies greatly depending on the stage at diagnosis and the treatment method. When appropriate decompression or vascularized bone grafting is performed in Stage I~II, satisfactory results in terms of wrist function and pain are often obtained. However, in Stage IIIb or higher, it is common for wrist range of motion and grip strength not to recover fully even after surgery, and chronic pain may persist.
Rates of return to work and sports vary with the treatment method and stage, but light daily function is mostly maintained even after proximal row carpectomy or carpal arthrodesis. In natural history studies, untreated Kienböck disease mostly progresses to Stage IV, resulting in pancarpal arthritis. Early detection and early treatment have the most decisive influence on prognosis, and diagnostic delay is the main cause of a poor prognosis.
There is no established method of primary prevention for Kienböck disease in adults. Recognizing risk factors is the best preventive approach. Improving the work environment to reduce occupational wrist overload (repetitive use of vibrating tools, handling heavy objects, etc.), appropriate rest and wearing wrist protective gear can contribute to risk reduction. If wrist pain persists for more than 2 weeks, it is important to receive specialist evaluation immediately so as not to miss the opportunity for early detection.
Once the disease has developed, preventing stage progression (secondary prevention) is key. The goal is to prevent lunate collapse and preserve wrist function through active treatment (decompression osteotomy or vascularized bone grafting) in the early stages. After treatment, recurrence or stage progression is detected early and addressed through regular imaging follow-up and functional assessment. When a coagulation disorder is confirmed, treatment of the underlying disease is given concurrently.